Rigel Pharmaceuticals, Inc. (RIGL)
41.22
-1.11
(-2.62%)
USD |
NASDAQ |
Dec 10, 16:00
41.20
-0.02
(-0.05%)
After-Hours: 20:00
Rigel Pharmaceuticals Cash from Investing (Quarterly): -33.18M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Eli Lilly & Co. | -2.983B |
| Catalyst Pharmaceuticals, Inc. | 0.00 |
| Amicus Therapeutics, Inc. | -1.299M |
| Perspective Therapeutics, Inc. | 13.99M |
| Nektar Therapeutics | -94.87M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 24.03M |
| Cash from Financing (Quarterly) | 4.271M |
| Free Cash Flow | 68.14M |
| Free Cash Flow Per Share (Quarterly) | 1.254 |
| Free Cash Flow to Equity (Quarterly) | 24.18M |
| Free Cash Flow to Firm (Quarterly) | 25.93M |
| Free Cash Flow Yield | 9.00% |